NCT06288399View on ClinicalTrials.gov

Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational Study

CompletedOBSERVATIONAL
Enrollment

1,316

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Obesity
Interventions
OTHER

No treatment given

No treatment given

Trial Locations (7)

113

National Diabetes and Endocrine Center, Muscat

620

Samail Polyclinic, Samail

13001

Al-Amiri Hospital, Kuwait City

52700

Al-Adan Hospital, Hadiya

85000

Farwaniya Hospital, Farwaniya

122104

Hamad General Hospital, Doha

PHCC, Doha

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY